• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清丙氨酸氨基转移酶水平持续正常的HBeAg阴性携带者中的乙肝病毒因素

Hepatitis B viral factors in HBeAg-negative carriers with persistently normal serum alanine aminotransferase levels.

作者信息

Lin Chih-Lin, Liao Li-Ying, Liu Chun-Jen, Yu Ming-Whei, Chen Pei-Jer, Lai Ming-Yang, Chen Ding-Shinn, Kao Jia-Horng

机构信息

Department of Gastroenterology, Ren-Ai branch, Taipei City Hospital, and Department of Internal Medicine, National Taiwan University Hospital, Taipei 100, Taiwan.

出版信息

Hepatology. 2007 May;45(5):1193-8. doi: 10.1002/hep.21585.

DOI:10.1002/hep.21585
PMID:17464993
Abstract

UNLABELLED

Chronic hepatitis B patients with high-normal serum ALT (levels of 0.5-1x upper limit of normal) are still at risk of liver disease progression. We thus investigated the correlation between serum ALT level and hepatitis B viral factors in HBeAg-negative carriers with persistently normal serum ALT level (PNALT). Baseline clinical and virological features of 414 HBeAg-negative carriers, including 176 (42.5%) with low-normal ALT (levels of less than 0.5x upper limit of normal) and 238 (57.5%) with high-normal ALT, were compared. Compared with HBV carriers with low-normal ALT, those with high-normal ALT were older (41 vs. 37 years, P<0.001) and had a greater frequency of serum HBV DNA level>10(4) copies/ml (63.4% vs. 47.5%, P<0.001) as well as a higher prevalence of basal core promoter T1762/A1764 mutant (36.5% vs. 24.2%, P=0.01). Multivariate analysis showed that factors associated with a high-normal serum ALT level included male sex [odds ratio (OR), 1.82; 95% confidence interval (CI), 1.10-3.01, P=0.019], increasing age (OR, <30 years: 1, reference; 30-39 years: 2.43, 95% CI, 1.18-5.03, P=0.016; 40-49 years: 4.22, 95% CI, 1.99-8.93, P<0.001; >or=50 years: 4.06, 95% CI, 1.69-9.78, P=0.002) and serum HBV DNA level>10(4) copies/ml (OR, 1.83; 95% CI, 1.07-3.13, P=0.027).

CONCLUSION

HBeAg-negative patients with persistently normal ALT are not a homogenous group, and those with high-normal ALT share some of the characteristics that have been associated with adverse long-term outcomes.

摘要

未标注

血清ALT处于高正常范围(水平为正常上限的0.5 - 1倍)的慢性乙型肝炎患者仍有肝病进展风险。因此,我们研究了血清ALT水平与血清ALT持续正常(PNALT)的HBeAg阴性携带者中乙肝病毒因素之间的相关性。比较了414例HBeAg阴性携带者的基线临床和病毒学特征,其中176例(42.5%)ALT处于低正常范围(水平低于正常上限的0.5倍),238例(57.5%)ALT处于高正常范围。与ALT处于低正常范围的HBV携带者相比,ALT处于高正常范围的患者年龄更大(41岁对37岁,P<0.001),血清HBV DNA水平>10⁴拷贝/ml的频率更高(63.4%对47.5%,P<0.001),基础核心启动子T1762/A1764突变的患病率也更高(36.5%对24.2%,P = 0.01)。多因素分析显示,与血清ALT高正常水平相关的因素包括男性[比值比(OR),1.82;95%置信区间(CI),1.10 - 3.01,P = 0.019]、年龄增加(OR,<30岁:1,参照;30 - 39岁:2.43,95% CI,1.18 - 5.03,P = 0.016;40 - 49岁:4.22,95% CI,1.99 - 8.93,P<0.001;≥50岁:4.06,95% CI,1.69 - 9.78,P = 0.002)以及血清HBV DNA水平>10⁴拷贝/ml(OR,1.83;95% CI,1.07 - 3.13,P = 0.027)。

结论

ALT持续正常的HBeAg阴性患者并非同质群体,ALT处于高正常范围的患者具有一些与不良长期结局相关的特征。

相似文献

1
Hepatitis B viral factors in HBeAg-negative carriers with persistently normal serum alanine aminotransferase levels.血清丙氨酸氨基转移酶水平持续正常的HBeAg阴性携带者中的乙肝病毒因素
Hepatology. 2007 May;45(5):1193-8. doi: 10.1002/hep.21585.
2
Viral level is an indicator of long-term outcome of hepatitis B virus e antigen-negative carriers with persistently normal serum alanine aminotransferase levels.病毒载量是乙型肝炎病毒 e 抗原阴性、持续血清丙氨酸氨基转移酶水平正常的携带者长期预后的一个指标。
J Viral Hepat. 2011 Jul;18(7):e191-9. doi: 10.1111/j.1365-2893.2010.01427.x. Epub 2011 Jan 11.
3
[Serum ALT and HBV DNA levels in patients with HBeAg-negative chronic hepatitis B].HBeAg阴性慢性乙型肝炎患者的血清谷丙转氨酶及乙肝病毒DNA水平
Taehan Kan Hakhoe Chi. 2003 Dec;9(4):284-92.
4
Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads.血清乙型肝炎表面抗原水平有助于预测低乙型肝炎病毒载量患者的疾病进展。
Hepatology. 2013 Feb;57(2):441-50. doi: 10.1002/hep.26041. Epub 2012 Dec 6.
5
[Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].[乙肝表面抗原(HBsAg)水平能否用于区分非活动性HBsAg携带者与HBeAg阴性慢性乙型肝炎?]
Mikrobiyol Bul. 2007 Jan;41(1):87-93.
6
Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT.慢性乙型肝炎病毒感染的无症状患者谷丙转氨酶持续正常时的病毒学和组织学特征
Gastroenterology. 2008 May;134(5):1376-84. doi: 10.1053/j.gastro.2008.02.075. Epub 2008 Feb 29.
7
Long-term outcome of hepatitis B e antigen-negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time.乙肝e抗原阴性乙肝表面抗原携带者的长期预后与丙氨酸氨基转移酶水平随时间的变化关系
Hepatology. 2009 Jun;49(6):1859-67. doi: 10.1002/hep.22878.
8
Level of hepatitis B virus DNA in inactive carriers with persistently normal levels of alanine aminotransferase.HBV DNA 载量在丙氨酸氨基转移酶(ALT)持续正常的非活动型乙肝病毒携带者中的水平。
Clin Gastroenterol Hepatol. 2010 Jun;8(6):535-40. doi: 10.1016/j.cgh.2010.03.006. Epub 2010 Mar 19.
9
Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection?对于乙肝e抗原阴性慢性乙型肝炎病毒感染的治疗决策而言,是否存在有意义的血清乙肝病毒DNA临界值水平?
Hepatology. 2008 Nov;48(5):1451-9. doi: 10.1002/hep.22518.
10
Spontaneous increases in alanine aminotransferase levels in asymptomatic chronic hepatitis B virus-infected patients.无症状慢性乙型肝炎病毒感染患者丙氨酸转氨酶水平的自发升高。
Gastroenterology. 2009 Apr;136(4):1272-80. doi: 10.1053/j.gastro.2009.01.011. Epub 2009 Jan 16.

引用本文的文献

1
Clinical Utility of Quantitative HBV Core Antibodies for Solving Diagnostic Dilemmas.定量 HBV 核心抗体在解决诊断难题中的临床应用
Viruses. 2023 Jan 28;15(2):373. doi: 10.3390/v15020373.
2
A Predictive Model to Evaluate the HbeAg Positivity of Chronic Hepatitis B Virus Patients in Clinics: A Cross-Sectional Study.评估慢性乙型肝炎病毒患者在临床中 HbeAg 阳性的预测模型:一项横断面研究。
Medicina (Kaunas). 2022 Sep 15;58(9):1279. doi: 10.3390/medicina58091279.
3
Management of Hepatitis B Virus Infection: 2018 Guidelines from the Canadian Association for the Study of Liver Disease and Association of Medical Microbiology and Infectious Disease Canada.
乙型肝炎病毒感染的管理:加拿大肝病研究协会和加拿大医学微生物学与传染病协会2018年指南。
Can Liver J. 2018 Dec 25;1(4):156-217. doi: 10.3138/canlivj.2018-0008. eCollection 2018 Fall.
4
The Role of Metabolic Factors and Steatosis in Treatment-Naïve Patients with Chronic Hepatitis B and Normal Alanine Aminotransferase.代谢因素和脂肪变性在初治慢性乙型肝炎且丙氨酸氨基转移酶正常患者中的作用
Infect Dis Ther. 2022 Jun;11(3):1133-1148. doi: 10.1007/s40121-022-00629-5. Epub 2022 Apr 10.
5
Chronic hepatitis B: the demise of the 'inactive carrier' phase.慢性乙型肝炎:“无症状携带者”阶段的终结。
Hepatol Int. 2021 Apr;15(2):290-300. doi: 10.1007/s12072-021-10137-2. Epub 2021 Feb 27.
6
A noninvasive model to predict liver histology for antiviral therapy decision in chronic hepatitis B with alanine aminotransferase < 2 upper limit of normal.一种用于预测慢性乙型肝炎患者肝组织学的非侵入性模型,该模型适用于丙氨酸氨基转移酶(ALT)< 正常值上限 2 倍的抗病毒治疗决策。
BMC Gastroenterol. 2021 Jan 6;21(1):4. doi: 10.1186/s12876-020-01576-6.
7
Cross-Protection of Hepatitis B Vaccination among Different Genotypes.不同基因型间乙肝疫苗的交叉保护作用
Vaccines (Basel). 2020 Aug 16;8(3):456. doi: 10.3390/vaccines8030456.
8
A novel diagnostic algorithm to predict significant liver inflammation in chronic hepatitis B virus infection patients with detectable HBV DNA and persistently normal alanine transaminase.一种新的诊断算法,用于预测 HBV DNA 可检测和丙氨酸氨基转移酶持续正常的慢性乙型肝炎病毒感染患者中显著肝脏炎症。
Sci Rep. 2018 Oct 18;8(1):15449. doi: 10.1038/s41598-018-33412-z.
9
Characterization and evaluation of liver fibrosis grade in patients with chronic hepatitis B virus infection and normal transaminases.慢性乙型肝炎病毒感染患者肝功能正常时肝纤维化程度的特征描述和评估。
Clin Mol Hepatol. 2018 Dec;24(4):384-391. doi: 10.3350/cmh.2018.0004. Epub 2018 Jul 4.
10
Plasma miRNA-122-5p and miRNA-151a-3p identified as potential biomarkers for liver injury among CHB patients with PNALT.血浆 miRNA-122-5p 和 miRNA-151a-3p 可作为伴有 PNALT 的 CHB 患者肝损伤的潜在生物标志物。
Hepatol Int. 2018 May;12(3):277-287. doi: 10.1007/s12072-018-9871-0. Epub 2018 Jun 7.